Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size, Status and Forecast 2021-2027

Enzyme-Linked Immunosorbent Assay (ELISA) Market Outlook 2027

The global Enzyme-Linked Immunosorbent Assay (ELISA) market size is projected to reach USD 221.3 Million by 2027, from USD 181 Million in 2020, at a CAGR of 3.6% during 2021-2027.

 

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.

 

The global average price of ELISA is in the decreasing trend, from 211 USD /Unit in 2011 to 196 USD/ Unit in 2015. with the situation of global economy, prices will be in decreasing trend in the following five years. The classification of ELISA includes ELISA Sets ELISA Kits, and the proportion of ELISA Kits in 2015 is about 61%.ELISA is widely used in IVD testing field.

 

USA is the largest supplier of ELISA, with a production market share nearly 48% in 2015. Europe is the second largest supplier of ELISA, enjoying production market share nearly 34% in 2015.

 

North america is the largest consumption place, with a consumption market share nearly 40% in 2015. following north america, europe is the second largest consumption place with the consumption market share of 26%. China is the world's largest import country.

 

Market competition is not intense. R&D Systems and Thermo Fisher Scientific, are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

 

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enzyme-Linked Immunosorbent Assay (ELISA) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enzyme-Linked Immunosorbent Assay (ELISA) market in terms of revenue.

 

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enzyme-Linked Immunosorbent Assay (ELISA) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enzyme-Linked Immunosorbent Assay (ELISA) market.

 

 

Enzyme-Linked Immunosorbent Assay (ELISA) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enzyme-Linked Immunosorbent Assay (ELISA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. 

Segment by Type

• ELISA Sets
• ELISA Kits 

Segment by Application

• ELISA in HIV
• ELISA in West Nile Virus
• Detecting Antigens or Antibodies
• Biodefense

By Region

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA 

By Company

• R&D Systems
• Thermo Fisher Scientific
• Ortho Clinical Diagnostics
• BD Biosciences
• ZEUS Scientific
• Bio-Rad Laboratories
• ALPCO
• Enzo Life Sciences
• BioMérieux
• EMD Millipore
• BioLegend
• LOEWE Biochemica
• Shenzhen YHLO Biotech